NASDAQ:ARWR

Arrowhead Pharmaceuticals Insider Trades

$82.07

+2.05 (+2.56 %)

(As of 01/22/2021 12:00 AM ET)

Add

Compare

Today's Range

$79.50

Now: $82.07▼

$82.24

50-Day Range

$65.29

MA: $77.79▼

$85.37

52-Week Range

$19.51

Now: $82.07▼

$86.75

Volume822,200 shs

Average Volume849,000 shs

Market Capitalization$8.43 billion

P/E RatioN/A

Dividend YieldN/A

Beta1.62

Arrowhead Pharmaceuticals (NASDAQ:ARWR) Insider Buying and Selling Activity

Insider Ownership Percentage:	4.00%
Insider Buying (Last 12 Months):	$59,470.00
Insider Selling (Last 12 Months):	$31,016,966.71

Insider Buying and Selling by Quarter

Arrowhead Pharmaceuticals (NASDAQ ARWR) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/15/2021	Douglas B. Given	Director	Sell	3,000	$83.28	$249,840.00
1/14/2021	James C Hamilton	SVP	Sell	10,000	$81.29	$812,900.00	130,064
1/12/2021	Kenneth Allen Myszkowski	CFO	Sell	13,038	$81.02	$1,056,338.76	445,446
1/7/2021	James Hassard	Insider	Sell	15,625	$75.00	$1,171,875.00	109,375
1/6/2021	Kenneth Allen Myszkowski	CFO	Sell	30,625	$72.44	$2,218,475.00	486,568
1/6/2021	Patrick O'brien	General Counsel	Sell	25,000	$72.41	$1,810,250.00	317,233
1/5/2021	James C Hamilton	SVP	Sell	19,375	$72.53	$1,405,268.75	171,200
1/4/2021	Douglas B Given	Director	Sell	4,000	$76.08	$304,320.00
12/17/2020	Douglas B. Given	Director	Sell	9,575	$79.32	$759,489.00
12/10/2020	William D Waddill	Director	Sell	3,000	$71.26	$213,780.00	26,800

12/9/2020	Christopher Richard Anzalone	CEO	Sell	38,676	$69.06	$2,670,964.56	2,521,561
11/19/2020	Martin Javier San	Insider	Sell	19,500	$69.39	$1,353,105.00	130,500
10/23/2020	Christopher Richard Anzalone	CEO	Sell	100,000	$58.21	$5,821,000.00
10/20/2020	Kenneth Allen Myszkowski	CFO	Sell	29,166	$54.04	$1,576,130.64	456,834
10/9/2020	Mauro Ferrari	Director	Sell	10,000	$48.00	$480,000.00	30,971
8/13/2020	Christopher Richard Anzalone	CEO	Sell	50,000	$41.35	$2,067,500.00	2,655,237
6/25/2020	Christopher Richard Anzalone	CEO	Sell	100,000	$38.81	$3,881,000.00	2,605,260
6/15/2020	Backer Marianne De	Director	Buy	500	$31.33	$15,665.00	13,000
5/12/2020	Michael S Perry	Director	Sell	36,000	$35.83	$1,289,880.00	14,100
4/27/2020	Bruce D Given	COO	Sell	300	$40.00	$12,000.00	851,934
4/20/2020	Bruce D Given	COO	Sell	23,515	$40.00	$940,600.00	862,793
4/14/2020	Douglas B Given	Director	Sell	25,000	$36.89	$922,250.00	155,925
3/16/2020	Backer Marianne De	Director	Buy	500	$23.94	$11,970.00	13,000
3/11/2020	Backer Marianne De	Director	Buy	500	$28.60	$14,300.00	13,000
2/27/2020	Backer Marianne De	Director	Buy	500	$35.07	$17,535.00	13,000
1/21/2020	Kenneth Allen Myszkowski	CFO	Sell	40,313	$49.44	$1,993,074.72	424,536
1/13/2020	Backer Marianne De	Director	Buy	500	$54.95	$27,475.00	13,000
1/6/2020	Bruce D Given	COO	Sell	35,613	$60.13	$2,141,409.69	882,759
1/6/2020	Kenneth Allen Myszkowski	CFO	Sell	20,000	$60.11	$1,202,200.00	403,592
1/6/2020	Patrick O'brien	General Counsel	Sell	14,625	$60.12	$879,255.00	267,406
12/12/2019	Christopher Richard Anzalone	CEO	Sell	100,000	$67.50	$6,750,000.00	2,048,684
12/2/2019	Christopher Richard Anzalone	CEO	Sell	37,967	$69.15	$2,625,418.05	2,116,160
11/1/2019	Kenneth Allen Myszkowski	CFO	Sell	37,884	$40.85	$1,547,561.40	351,420
10/10/2019	Christopher Richard Anzalone	CEO	Sell	56,325	$31.83	$1,792,824.75	2,178,228
9/24/2019	Christopher Richard Anzalone	CEO	Sell	66,645	$28.20	$1,879,389.00	2,146,153
9/20/2019	Christopher Richard Anzalone	CEO	Sell	4,250	$29.00	$123,250.00	2,146,153
9/11/2019	Michael S Perry	Director	Sell	85,000	$30.00	$2,550,000.00	121,000
9/9/2019	Michael S Perry	Director	Sell	100,000	$28.90	$2,890,000.00	121,000
6/26/2019	Mauro Ferrari	Director	Sell	17,756	$27.61	$490,243.16	1,900
5/28/2019	Patrick O'brien	General Counsel	Sell	30,000	$24.88	$746,400.00	203,000
5/21/2019	Kenneth Allen Myszkowski	CFO	Sell	27,071	$22.00	$595,562.00	278,536
4/3/2019	Christopher Richard Anzalone	CEO	Sell	50,000	$19.30	$965,000.00
3/1/2019	Bruce D Given	COO	Sell	42,500	$19.99	$849,575.00	687,106
2/26/2019	Douglas B Given	Director	Sell	65,000	$19.25	$1,251,250.00	175,130
2/25/2019	Bruce D Given	COO	Sell	42,500	$18.98	$806,650.00	687,106
2/22/2019	Douglas B Given	Director	Sell	3,000	$18.05	$54,150.00	175,130
2/19/2019	Bruce D Given	COO	Sell	68,750	$17.86	$1,227,875.00	644,606
2/19/2019	Kenneth Allen Myszkowski	CFO	Sell	8,000	$18.00	$144,000.00	313,607
2/15/2019	Bruce D Given	COO	Sell	26,250	$17.67	$463,837.50	644,606
2/12/2019	Bruce D Given	COO	Sell	242,834	$16.04	$3,895,057.36	859,523
2/8/2019	Bruce D Given	COO	Sell	46,167	$15.34	$708,201.78	859,523
2/5/2019	Bruce D Given	COO	Sell	22,500	$14.48	$325,800.00	847,856
2/1/2019	Bruce D Given	COO	Sell	28,500	$13.85	$394,725.00	870,356
1/23/2019	Bruce D Given	COO	Sell	169,500	$13.54	$2,295,030.00	916,356
1/22/2019	Douglas B Given	Director	Sell	3,000	$13.58	$40,740.00	178,130
1/18/2019	Patrick O'brien	General Counsel	Sell	72,000	$14.43	$1,038,960.00	233,000
1/17/2019	Kenneth Allen Myszkowski	CFO	Sell	81,875	$14.55	$1,191,281.25	305,607
1/14/2019	Bruce D Given	COO	Sell	42,666	$14.40	$614,390.40	1,110,022
1/14/2019	Zhen Li	VP	Sell	40,500	$14.34	$580,770.00	201,700
1/11/2019	William D Waddill	Director	Sell	8,500	$14.77	$125,545.00	46,500
1/2/2019	Bruce D Given	COO	Sell	20,000	$11.98	$239,600.00	1,118,356
1/2/2019	Kenneth Allen Myszkowski	CFO	Sell	8,333	$11.98	$99,829.34	395,815
12/27/2018	Douglas B. Given	Director	Sell	3,000	$12.00	$36,000.00
12/19/2018	Christopher Richard Anzalone	CEO	Sell	90,000	$13.92	$1,252,800.00
12/12/2018	Christopher Richard Anzalone	CEO	Sell	90,000	$14.07	$1,266,300.00
11/23/2018	Douglas B. Given	Director	Sell	3,000	$12.74	$38,220.00
11/9/2018	Christopher Richard Anzalone	CEO	Sell	81,500	$14.39	$1,172,785.00	1,727,755
10/19/2018	Peter Brian Leone	VP	Sell	131,137	$13.49	$1,769,038.13	160,000
9/6/2018	Kenneth Allen Myszkowski	CFO	Sell	45,000	$19.34	$870,300.00	335,815
9/4/2018	Christopher Richard Anzalone	CEO	Sell	164,834	$14.45	$2,381,851.30	1,868,789
8/31/2018	Christopher Richard Anzalone	CEO	Sell	100,000	$14.45	$1,445,000.00	1,868,789
6/19/2018	Kenneth Allen Myszkowski	CFO	Sell	20,000	$14.01	$280,200.00	330,815
5/31/2018	Kenneth Allen Myszkowski	CFO	Sell	14,000	$11.00	$154,000.00	312,215
4/24/2018	Douglas B. Given	Director	Sell	25,000	$6.63	$165,750.00
3/27/2018	Kenneth Allen Myszkowski	CFO	Sell	20,000	$8.00	$160,000.00	330,815
3/15/2018	Christopher Richard Anzalone	CEO	Sell	300,000	$7.43	$2,229,000.00	2,194,789
3/13/2018	Christopher Richard Anzalone	CEO	Sell	100,000	$7.43	$743,000.00	2,194,789
3/5/2018	Bruce D Given	COO	Sell	20,000	$6.73	$134,600.00	908,356
1/1/2018	Bruce D Given	COO	Sell	20,000	$3.69	$73,800.00	948,356
10/14/2016	Douglas B. Given	Director	Sell	12,000	$6.72	$80,640.00
8/23/2016	Kenneth Allen Myszkowski	CFO	Sell	6,900	$8.00	$55,200.00	128,789
8/22/2016	Kenneth Allen Myszkowski	CFO	Sell	13,100	$8.00	$104,800.00	128,789
12/30/2015	Kenneth Allen Myszkowski	CFO	Sell	23,347	$6.13	$143,117.11	135,000
10/28/2015	Mauro Ferrari	Director	Buy	400	$7.62	$3,048.00
10/9/2015	Mauro Ferrari	Director	Buy	1,900	$6.19	$11,761.00
1/5/2015	David L Lewis	Insider	Sell	15,000	$8.01	$120,150.00
10/15/2014	Christopher Richard Anzalone	CEO	Buy	16,000	$6.32	$101,120.00
10/1/2014	Charles Mckenney	Director	Sell	2,500	$14.70	$36,750.00
9/30/2014	David L Lewis	Insider	Sell	15,000	$15.02	$225,300.00
9/26/2014	Douglas B Given	Director	Sell	2,000	$15.24	$30,480.00
6/9/2014	Charles Mckenney	Director	Sell	22,000	$14.32	$315,040.00
2/12/2014	Kenneth Allen Myszkowski	CFO	Sell	16,000	$18.77	$300,320.00
2/7/2014	Edward W Frykman	Director	Sell	3,148	$15.98	$50,305.04

(Data available from 1/1/2013 forward)

This page was last updated on 1/25/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Arrowhead Pharmaceuticals Insider Trades

Adding

Adding

Adding Arrowhead Pharmaceuticals, Inc.

Insider Trades

Arrowhead Pharmaceuticals (NASDAQ:ARWR) Insider Buying and Selling Activity

Insider Buying and Selling by Quarter

Arrowhead Pharmaceuticals (NASDAQ ARWR) Insider Trading History

30 Days of MarketBeat All Access for $1.00

Options Trading from Scratch

Market Data and Calendars

Investing Education and Resources